NCT02376153

Brief Summary

This is a prospective, randomized, blinded clinical trial to determine if the Air Barrier System device reduces the incidence of surgical site infection after total hip replacement, acetabular repair, posterior spinal fusion, and prosthetic vascular graft procedures.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
816

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 25, 2015

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 3, 2015

Completed
2 months until next milestone

Study Start

First participant enrolled

April 24, 2015

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
Last Updated

September 6, 2018

Status Verified

September 1, 2018

Enrollment Period

4.3 years

First QC Date

February 25, 2015

Last Update Submit

September 4, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • Clinical incidence of surgical site infection

    Subjects are followed for one year post-surgery for onset of prosthesis-related infections .

    One-year post surgery

Study Arms (2)

ABS deployed and active

EXPERIMENTAL

Air Barrier System (ABS) will be deployed onto the surgical field and activated.

Device: ABS deployed and active

ABS deployed and NOT active

SHAM COMPARATOR

Air Barrier System (ABS) will be deployed onto the surgical field and NOT activated. This is a sham comparator to reduce the influence of the presence of the device and provide user blinding.

Device: ABS deployed and NOT active

Interventions

ABS is deployed onto surgical field and is turned on.

ABS deployed and active

ABS is deployed onto surgical field and is NOT turned on.

ABS deployed and NOT active

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Total hip arthroplasty;
  • Acetabular repair with instrumentation;
  • Posterior lumbar, cervical, or thoracic (up to and including 6 vertebral levels) spine fusion with instrumentation and vascular prosthetic graft implantation.

You may not qualify if:

  • History of prior prosthesis infection;
  • Active infection;
  • Open traumatic wounds as is the case after some acetabular fractures.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Michael E. DeBakey VA Medical Center

Houston, Texas, 77030, United States

RECRUITING

MeSH Terms

Conditions

Prosthesis-Related Infections

Condition Hierarchy (Ancestors)

InfectionsPostoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Sean Self

    Investigator

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 25, 2015

First Posted

March 3, 2015

Study Start

April 24, 2015

Primary Completion

August 1, 2019

Study Completion

October 1, 2019

Last Updated

September 6, 2018

Record last verified: 2018-09

Data Sharing

IPD Sharing
Will not share

There is no current plan.

Locations